Analyst Ratings for Tourmaline Bio (TRML)
TRML Rating Summary
TRML Price Target Summary
- Highest: $48.00 (Truist Securities)
- Lowest: $47.50 (Jefferies)
- Average: $47.90
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$47.90 (-0.2%)
* Over Last 12-Mos
Rating Score: 1.1 / 10
Percentile Rank: 8%
Rating Score: 1.1 / 10
Percentile Rank: 8%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/15/2025 | BMO Capital | Kostas Biliouris | Downgrade | Market Perform (Outperform) |
48.00 (35.00) |
47.60 (47.98) |
0.8% | Details |
| 9/11/2025 | Piper Sandler | Yasmeen Rahimi | Downgrade | Neutral (Overweight) |
N/A (N/A) |
47.60 (47.98) |
0.8% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
